{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:11:31Z","timestamp":1786979491734,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1007\/bf03345264","type":"journal-article","created":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T06:02:08Z","timestamp":1396072928000},"page":"1136-1142","source":"Crossref","is-referenced-by-count":55,"title":["Derangement of glucose metabolism in hyperparathyroidism"],"prefix":"10.1007","volume":"26","author":[{"given":"M.","family":"Procopio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Borretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,18]]},"reference":[{"key":"BF03345264_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2265.1994.tb02442.x","volume":"40","author":"S Kumar","year":"1994","unstructured":"Kumar S, Olukoga AO, Gordon C, et al. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol (Oxf) 1994, 40: 47\u201353.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03345264_CR2","first-page":"102","volume":"24","author":"RA Fronzo De","year":"1983","unstructured":"De Fronzo RA, Smith D, Alvestrand A. Insulin action in uremia. Kidney Int 1983, 24: 102\u201324.","journal-title":"Kidney Int"},{"key":"BF03345264_CR3","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1210\/jcem.84.7.5842-1","volume":"84","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg SJ, Bilezikian JP, Bone HG, Talpos GB, Horwitz MJ, Stewart AF. Therapeutic controversy in primary hyperparathyroidism. J Clin Endocrinol Metab 1999, 84: 2275\u201385.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345264_CR4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-114-7-593","volume":"114","author":"Consensus Development Conference Panel.","year":"1991","unstructured":"Consensus Development Conference Panel. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference Statement. Ann Intern Med 1991, 114: 593\u20137.","journal-title":"Ann Intern Med"},{"key":"BF03345264_CR5","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","volume":"87","author":"JP Bilezikian","year":"2002","unstructured":"Bilezikian JP, Potts JT, Fuleihan GEH, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 2002, 87: 5353\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345264_CR6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2796.1998.00366.x","volume":"244","author":"S Valdermarsson","year":"1998","unstructured":"Valdermarsson S, Lindblom P, Bergenfelz A. Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment. J Intern Med 1998, 244: 241\u20139.","journal-title":"J Intern Med"},{"key":"BF03345264_CR7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.0300-0664.2001.01468.x","volume":"56","author":"E Hagstrom","year":"2002","unstructured":"Hagstrom E, Lundgren E, Lithell H, et al. Normalized dys-ipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol (Oxf) 2002, 56: 253\u201360.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03345264_CR8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1464-5491.2002.00809.x","volume":"19","author":"M Procopio","year":"2002","unstructured":"Procopio M, Magro G, Cesario F, et al. The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism. Diabet Med 2002, 19: 958\u201361.","journal-title":"Diabet Med"},{"key":"BF03345264_CR9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.1999.00651.x","volume":"50","author":"A Piovesan","year":"1999","unstructured":"Piovesan A, Molineri N, Casasso F, et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 1999, 50: 321\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03345264_CR10","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1210\/jcem.85.10.6880","volume":"85","author":"JC Smith","year":"2000","unstructured":"Smith JC, Page MD, John R, et al. Augmentation of centra arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000, 85: 3515\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345264_CR11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/eje.0.1470453","volume":"147","author":"V Nuzzo","year":"2002","unstructured":"Nuzzo V, Tauchmanov\u00e0 L, Fonderico F, et al. Increased inti-ma-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol 2002, 147: 453\u20139.","journal-title":"Eur J Endocrinol"},{"key":"BF03345264_CR12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1210\/jcem-55-2-303","volume":"55","author":"JC Nainby-Luxmoore","year":"1982","unstructured":"Nainby-Luxmoore JC, Langford HG, Nelson NC, et al. A case-comparison study of hypertension and hyperparathyroidism. J Clin Endocrinol Metab 1982, 55: 303\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345264_CR13","first-page":"1","volume":"102","author":"M Palmer","year":"1987","unstructured":"Palmer M, Adami HO, Bergstrom R, et al. Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 1987, 102: 1\u20137.","journal-title":"Surgery"},{"key":"BF03345264_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(87)91906-4","volume":"1","author":"M Palmer","year":"1987","unstructured":"Palmer M, Adami HO, Bergstrom R, Jakobsson S, Akerstrom G, Ljunghall S. Survival and renal function in persons with untreated hypercalcemia: a population-based cohort study with 14 years of follow up. Lancet 1987, 1: 59\u201362.","journal-title":"Lancet"},{"key":"BF03345264_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","volume":"104","author":"RA Wermers","year":"1998","unstructured":"Wermers RA, Khosla S, Atkinson EJ, et al. Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med 1998, 104: 115\u201322.","journal-title":"Am J Med"},{"key":"BF03345264_CR16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2362.1983.tb00116.x","volume":"13","author":"S Ljunghall","year":"1983","unstructured":"Ljunghall S, Palmer M, Akerstrom G, et al. Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur J Clin Invest 1983, 13: 373\u20137.","journal-title":"Eur J Clin Invest"},{"key":"BF03345264_CR17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1464-5491.1991.tb01678.x","volume":"8","author":"WH Taylor","year":"1991","unstructured":"Taylor WH. The prevalence of diabetes mellitus in patients with primary hyperparathyroidism and among their relatives. Diabet Med 1991, 8: 683\u20137.","journal-title":"Diabet Med"},{"key":"BF03345264_CR18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/(SICI)1096-9136(199705)14:5<386::AID-DIA362>3.0.CO;2-3","volume":"14","author":"WH Taylor","year":"1997","unstructured":"Taylor WH, Khaleeli AA. Prevalence of primary hyperparathyroidism in patients with diabetes mellitus. Diabet Med 1997, 14: 386\u20139.","journal-title":"Diabet Med"},{"key":"BF03345264_CR19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/dmrr.199","volume":"17","author":"WH Taylor","year":"2001","unstructured":"Taylor WH, Khaleeli AA. Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev 2001, 17: 175\u201380.","journal-title":"Diabetes Metab Res Rev"},{"key":"BF03345264_CR20","first-page":"618","volume":"140","author":"S Werner","year":"1974","unstructured":"Werner S, Hjiern B, Sjoberg HE. Primary hyperparathyroidism. Analysis of findings in a series of 129 patients. Acta Chir Scand 1974, 140: 618\u201325.","journal-title":"Acta Chir Scand"},{"issue":"Suppl2","key":"BF03345264_CR21","first-page":"N68","volume":"17","author":"IL Nilsson","year":"2002","unstructured":"Nilsson IL, Yin L, Lundgren E, Rastad J, Ekbom A. Clinica presentation of primary hyperparathyroidism in Europe-nationwide cohort analysis on mortality from non malignant causes. J Bone Miner Res 2002, 17 (Suppl 2): N68\u201374.","journal-title":"J Bone Miner Res"},{"key":"BF03345264_CR22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-2007-1003676","volume":"23","author":"D Micic","year":"1991","unstructured":"Micic D, Kendereski A, Popovic V, Manojlovic D, Micic J. nsulin sensitivity in patients with primary hyperparathyroidism before and after parathyroidectomy: sequentia euglycemic insulin clamp studies. Horm Metab Res 1991, 23: 288\u20139.","journal-title":"Horm Metab Res"},{"key":"BF03345264_CR23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudensky AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412\u20139.","journal-title":"Diabetologia"},{"key":"BF03345264_CR24","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22: 1462\u201370.","journal-title":"Diabetes Care"},{"issue":"Suppl6","key":"BF03345264_CR25","first-page":"45","volume":"25","author":"M Procopio","year":"2002","unstructured":"Procopio M, Cesario F, Piovesan A, et al. Insulin resistance and metabolic syndrome in primary hyperparathyroidism. J Endocrinol Invest 2002, 25 (Suppl 6): 45 (Abstract).","journal-title":"J Endocrinol Invest"},{"key":"BF03345264_CR26","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM198011273032203","volume":"303","author":"RA DeFronzo","year":"1980","unstructured":"DeFronzo RA, Lang R. Hypophosphatemia and glucose tolerance. Evidence for tissue insensitivity to insulin. N Engl J Med 1980, 303: 1259\u201363.","journal-title":"N Engl J Med"},{"key":"BF03345264_CR27","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/meta.2000.17708","volume":"49","author":"KC Chiu","year":"2000","unstructured":"Chiu KC, Chuang L, Lee NP, et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone evel. Metabolism 2000, 49: 1501\u20135.","journal-title":"Metabolism"},{"key":"BF03345264_CR28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ndt\/12.5.933","volume":"12","author":"D Fliser","year":"1997","unstructured":"Fliser D, Franek E, Fode P, et al. Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. Nephrol Dial Transplant 1997, 12: 933\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03345264_CR29","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0026-0495(97)90212-2","volume":"46","author":"NJ Wareham","year":"1997","unstructured":"Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, Hales CN. Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism 1997, 46: 1171\u20137.","journal-title":"Metabolism"},{"key":"BF03345264_CR30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-2007-1018671","volume":"15","author":"A Brauman","year":"1983","unstructured":"Brauman A, Gilboa Y, Hertzeanu I. The effect of acute hypercalcemia on the insulin response to OGTT. Horm Metab Res 1983, 15: 204\u20135.","journal-title":"Horm Metab Res"},{"key":"BF03345264_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.0954-6820.1982.tb01899.x","volume":"211","author":"DEH Andersson","year":"1982","unstructured":"Andersson DEH, Rojdmark S, Hed R, Sundblad L. Hypercalcemic and calcium-antagonistic effects on insulin release and oral glucose tolerance in man. Acta Med Scand 1982, 211: 35\u201343.","journal-title":"Acta Med Scand"},{"key":"BF03345264_CR32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM197503062921003","volume":"292","author":"K Yasuda","year":"1975","unstructured":"Yasuda K, Hurukawa Y, Okuyama M, Kikuchi M, Yoshinaga K. Glucose tolerance and insulin secretion in patients with parathyroid disorders. Effect of serum calcium on insulin release. N Engl J Med 1975, 292: 501\u20134.","journal-title":"N Engl J Med"},{"key":"BF03345264_CR33","first-page":"713","volume":"86","author":"SI Mc Farlane","year":"2001","unstructured":"Mc Farlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001, 86: 713\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345264_CR34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00000658-198804000-00010","volume":"207","author":"MP Bannon","year":"1988","unstructured":"Bannon MP, van Heerden JA, Palumbo PJ, Ilstrup DM. The relationship between primary hyperparathyroidism and diabetes mellitus. Ann Surg 1988, 207: 430\u20133.","journal-title":"Ann Surg"},{"key":"BF03345264_CR35","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1067\/msy.2099.101436","volume":"126","author":"ML Richards","year":"1999","unstructured":"Richards ML, Thompson NW. Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy? Surgery 1999, 126: 1160\u20136.","journal-title":"Surgery"},{"key":"BF03345264_CR36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<80::AID-DIA285>3.0.CO;2-W","volume":"14","author":"JD Quin","year":"1997","unstructured":"Quin JD, Gumpert JR. Remission of non-insulin-dependent diabetes mellitus following resection of a parathyroid adenoma. Diabet Med 1997, 14: 80\u20131.","journal-title":"Diabet Med"},{"key":"BF03345264_CR37","first-page":"227","volume":"36","author":"RHK Mak","year":"1989","unstructured":"Mak RHK. Insulin secretion in uremia: effect of parathyroid hormone and vitamin D metabolites. Kidney Int 1989, 36: 227\u201330.","journal-title":"Kidney Int"},{"key":"BF03345264_CR38","first-page":"168","volume":"262","author":"P Castellino","year":"1992","unstructured":"Castellino P, Solino A, Luzi L, et al. Glucose and amino acid metabolism in chronic renal failure: effects of insulin and amino acids. Am J Physiol 1992, 262: 168\u201376.","journal-title":"Am J Physiol"},{"key":"BF03345264_CR39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/jcem-60-2-229","volume":"60","author":"RHK Mak","year":"1985","unstructured":"Mak RHK, Bertinelli A, Turner C, Haycock B, Chantler C. The influence of hyperparathyroidism on glucose metabolism in uremia. J Clin Endocrinol Metab 1985, 60: 229\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345264_CR40","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0026-0495(85)90148-9","volume":"34","author":"H Graf","year":"1985","unstructured":"Graf H, Prager R, Kovarik J, Luger A, Schernthaner G, Pinggera WF. Glucose metabolism and insulin sensitivity in patients on chronic hemodialysis. Metabolism 1985, 34: 974\u20137.","journal-title":"Metabolism"},{"key":"BF03345264_CR41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ki.1995.24","volume":"47","author":"A Kautzky-Willer","year":"1995","unstructured":"Kautzky-Willer A, Pacini G, Barnas U, et al. Intravenous cal-citriol normalizes insulin sensitivity in uremic patients. Kidney Int 1995, 47: 200\u20136.","journal-title":"Kidney Int"},{"key":"BF03345264_CR42","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1985.190","volume":"28","author":"R Baczynsky","year":"1985","unstructured":"Baczynsky R, Massry SG, Magott M, EL-Belbessi S, Kohan R, Brautbar N. Effect of parathyroid hormone on energy metabolism of skeletal muscle. Kidney Int 1985, 28: 722\u20137.","journal-title":"Kidney Int"},{"key":"BF03345264_CR43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000186953","volume":"61","author":"RHK Mak","year":"1992","unstructured":"Mak RHK, De Fronzo RA. Glucose and insulin metabolism in uremia. Nephron 1992, 61: 377\u201382.","journal-title":"Nephron"},{"key":"BF03345264_CR44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI111765","volume":"75","author":"M Akmal","year":"1985","unstructured":"Akmal M, Massry SG, Glodstein DA, Fanti P, Weisz A, De Fronzo RA. Role of the parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 1985, 75: 1037\u201344.","journal-title":"J Clin Invest"},{"key":"BF03345264_CR45","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ki.1988.112","volume":"33","author":"GZ Fadda","year":"1988","unstructured":"Fadda GZ, Akmal M, Premdas FH, Lipson LG, Massry SG. nsulin release from pancreatic islets: effects of CRF and excess PTH. Kidney Int 1988, 33: 1066\u201372.","journal-title":"Kidney Int"},{"key":"BF03345264_CR46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0272-6386(12)80727-X","volume":"21","author":"SG Massry","year":"1993","unstructured":"Massry SG, Fadda GZ. Chronic renal failure is a state of cellular calcium toxicity. Am J Kidney Dis 1993, 21: 81\u20136.","journal-title":"Am J Kidney Dis"},{"key":"BF03345264_CR47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1172\/JCI114979","volume":"87","author":"GZ Fadda","year":"1991","unstructured":"Fadda GZ, Hajjar SM, Perna AF, Zhuo XJ, Lipson LG, Massry SG. On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest 1991, 87: 255\u201361.","journal-title":"J Clin Invest"},{"key":"BF03345264_CR48","first-page":"187","volume":"22","author":"F Bergesio","year":"1996","unstructured":"Bergesio F, Bandini S, Cresci B, et al. Hyperparathyroidism: is it really the major factor affecting glucose tolerance in uremia? Miner Electrolyte Metab 1996, 22: 187\u201391.","journal-title":"Miner Electrolyte Metab"},{"key":"BF03345264_CR49","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1042\/cs0870533","volume":"87","author":"S Lin","year":"1994","unstructured":"Lin S, Lin Y, Lu K, et al. Effects of intravenous calcitriol on lipid profiles and glucose tolerance in uremic patients with secondary hyperparathyroidism. Clin Sci (Lond) 1994, 87: 533\u20138.","journal-title":"Clin Sci (Lond)"},{"key":"BF03345264_CR50","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ki.1992.159","volume":"41","author":"RHK Mak","year":"1992","unstructured":"Mak RHK. Intravenous 1.25 dihydroxycholecalciferol corrects glucose tolerance in hemodialysis patients. Kidney Int 1992, 41: 1049\u201354.","journal-title":"Kidney Int"},{"key":"BF03345264_CR51","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ki.1981.62","volume":"19","author":"MK Chan","year":"1981","unstructured":"Chan MK, Varghese Z, Moorhead JF. Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int 1981, 19: 625\u201337.","journal-title":"Kidney Int"},{"key":"BF03345264_CR52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000188395","volume":"68","author":"S Hong","year":"1994","unstructured":"Hong S, Yang D. Insulin levels and fibrinolytic activity in patients with end-stage renal disease. Nephron 1994, 68: 329\u201333.","journal-title":"Nephron"},{"key":"BF03345264_CR53","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","volume":"12","author":"SK Ganesch","year":"2001","unstructured":"Ganesch SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), CaxPO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001, 12: 2131\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"BF03345264_CR54","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","volume":"22","author":"P Lips","year":"2001","unstructured":"Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001, 22: 477\u2013501.","journal-title":"Endocr Rev"},{"key":"BF03345264_CR55","first-page":"67","volume":"93","author":"M Mc Kenna","year":"1992","unstructured":"Mc Kenna M. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992, 93: 67\u20139.","journal-title":"Am J Med"},{"key":"BF03345264_CR56","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.6250216","volume":"209","author":"BJ Frankel","year":"1980","unstructured":"Frankel BJ, Heldt AM, Grodsksy GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980, 209: 823\u20135.","journal-title":"Science"},{"key":"BF03345264_CR57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/endo-119-1-84","volume":"119","author":"C Cade","year":"1986","unstructured":"Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-defi-cient rat in vivo. Endocrinology 1986, 119: 84\u201390.","journal-title":"Endocrinology"},{"key":"BF03345264_CR58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02427083","volume":"29","author":"O Gedik","year":"1986","unstructured":"Gedik O, Akalin S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 1986, 29: 142\u20135.","journal-title":"Diabetologia"},{"key":"BF03345264_CR59","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/BF00422375","volume":"38","author":"BJ Boucher","year":"1995","unstructured":"Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJW. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia 1995, 38: 1239\u201345.","journal-title":"Diabetologia"},{"key":"BF03345264_CR60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0221-8747(83)90010-3","volume":"5","author":"TL Storm","year":"1983","unstructured":"Storm TL, Sorensen OH, Lund B, et al. Vitamin D metabolism in insulin-dependent diabetes mellitus. Metab Bone Dis Relat Res 1983, 5: 107\u201310.","journal-title":"Metab Bone Dis Relat Res"},{"key":"BF03345264_CR61","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1210\/jcem-49-3-462","volume":"49","author":"H Heat","year":"1983","unstructured":"Heat H, Lambert PW, Service FJ, et al. Calcium homeostasis in diabetes mellitus. J Clin Endocrinol Metab 1983, 49: 462\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345264_CR62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1079\/BJN19980055","volume":"79","author":"BJ Boucher","year":"1998","unstructured":"Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome \u2018X\u2019? Br J Nutr 1998, 79: 315\u201327.","journal-title":"Br J Nutr"},{"key":"BF03345264_CR63","first-page":"352","volume":"38","author":"J Kocian","year":"1992","unstructured":"Kocian J. Diabetic osteopathy. Favorable effect of treatment of osteomalacia with vitamin D and calcium on high blood glucose levels. Vnitr Lek 1992, 38: 352\u20136.","journal-title":"Vnitr Lek"},{"key":"BF03345264_CR64","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ajcn\/59.5.1083","volume":"59","author":"E Orwoll","year":"1994","unstructured":"Orwoll E, Riddle M, Prince M. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1994, 59: 1083\u20137.","journal-title":"Am J Clin Nutr"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345264.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03345264\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:16:58Z","timestamp":1648703818000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03345264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":64,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["BF03345264"],"URL":"https:\/\/doi.org\/10.1007\/bf03345264","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}